Peter B. Reiner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter B. Reiner has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Maartje Schermer
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Netherlands
2 shared publications Nicholas S. Fitz
National Core for Neuroethics, University of British Columbia
2 shared publicationsRoland Nadler
University of British Columbia
2 shared publications- Roland Nadler
Peter A. Allard School of Law, University of British Columbia, Vancouver, Canada.
2 shared publications - Andreas Günter Franke
Department of Psychiatry and Psychotherapy, University Medical Centre, Mainz, Germany
1 shared publication Anthony Aguirre
Physics and a co-founder of the Future of Life Institute, University of California at Santa Cruz, 1156 High Street, Santa Cruz, CA 95060
1 shared publication
Latest Publications
- 4 August 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Technology and Society
- Vol. 1 (3) , 128-137
AI Loyalty: A New Paradigm for Aligning Stakeholder Interests
When we consult a doctor, lawyer, or financial advisor, we assume that they are acting in our best interests. But what should we assume when we interact with an artificial intelligence (AI) system? AI-driven personal assistants such as Alexa and Siri already serve as interfaces between consumers and information on the web, and users routinely rely upon these and similar systems to take automated actions or provide information. Superficially, they may appear to be acting according to user interests, but many are designed with embedded conflicts of interests. To address this problem, we introduce the concept of AI loyalty. AI systems are loyal to the degree that they minimize, and make transparent, conflicts of interest, and act in ways that prioritize the interests of users. Loyal AI products hold obvious appeal for the end-user and could promote the alignment of the long-term interests of AI developers and customers. To this end, we suggest criteria for assessing whether an AI system is acting in a manner that is loyal to the user, and argue that AI loyalty should be deliberately considered during the technological design process alongside other important values in AI ethics such as fairness, accountability privacy, and equity.
- 4 August 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Technology and Society
- Vol. 1 (3) , 128-137
AI Loyalty: A New Paradigm for Aligning Stakeholder Interests
When we consult a doctor, lawyer, or financial advisor, we assume that they are acting in our best interests. But what should we assume when we interact with an artificial intelligence (AI) system? AI-driven personal assistants such as Alexa and Siri already serve as interfaces between consumers and information on the web, and users routinely rely upon these and similar systems to take automated actions or provide information. Superficially, they may appear to be acting according to user interests, but many are designed with embedded conflicts of interests. To address this problem, we introduce the concept of AI loyalty. AI systems are loyal to the degree that they minimize, and make transparent, conflicts of interest, and act in ways that prioritize the interests of users. Loyal AI products hold obvious appeal for the end-user and could promote the alignment of the long-term interests of AI developers and customers. To this end, we suggest criteria for assessing whether an AI system is acting in a manner that is loyal to the user, and argue that AI loyalty should be deliberately considered during the technological design process alongside other important values in AI ethics such as fairness, accountability privacy, and equity.
- 1 January 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IT Professional
- Vol. 22 (1) , 39-42
Ethics in the Digital Era: Nothing New?
- 1 January 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IT Professional
- Vol. 22 (1) , 39-42
Ethics in the Digital Era: Nothing New?
- Open Access
- 27 July 2017
- Published by Springer Nature in Neuroethics
- Vol. 10 (3) , 405-417
Public Attitudes Towards Moral Enhancement. Evidence that Means Matter Morally
To gain insight into the reasons that the public may have for endorsing or eschewing pharmacological moral enhancement for themselves or for others, we used empirical tools to explore public attitudes towards these issues. Participants (N = 293) from the United States were recruited via Amazon’s Mechanical Turk and were randomly assigned to read one of several contrastive vignettes in which a 13-year-old child is described as bullying another student in school and then is offered an empathy-enhancing program. The empathy-enhancing program is described as either involving taking a pill or playing a video game on a daily basis for four weeks. In addition, participants were asked to imagine either their own child bullying another student at school, or their own child being bullied by another student. This resulted in a 2 × 2 between-subjects design. In an escalating series of morally challenging questions, we asked participants to rate their overall support for the program; whether they would support requiring participation; whether they would support requiring participation of children who are at higher risk to become bullies in the future; whether they would support requiring participation of all children or even the entire population; and whether they would be willing to participate in the program themselves. We found that people were significantly more troubled by pharmacological as opposed to non-pharmacological moral enhancement interventions. The results indicate that members of the public for the greater part oppose pharmacological moral bioenhancement, yet are open to non-biomedical means to attain moral enhancement. [248 words].
- 27 July 2017
- Published by Springer Nature in Neuroethics
- Vol. 10 (3) , 405-417
Open AccessPublic Attitudes Towards Moral Enhancement. Evidence that Means Matter Morally
To gain insight into the reasons that the public may have for endorsing or eschewing pharmacological moral enhancement for themselves or for others, we used empirical tools to explore public attitudes towards these issues. Participants (N = 293) from the United States were recruited via Amazon’s Mechanical Turk and were randomly assigned to read one of several contrastive vignettes in which a 13-year-old child is described as bullying another student in school and then is offered an empathy-enhancing program. The empathy-enhancing program is described as either involving taking a pill or playing a video game on a daily basis for four weeks. In addition, participants were asked to imagine either their own child bullying another student at school, or their own child being bullied by another student. This resulted in a 2 × 2 between-subjects design. In an escalating series of morally challenging questions, we asked participants to rate their overall support for the program; whether they would support requiring participation; whether they would support requiring participation of children who are at higher risk to become bullies in the future; whether they would support requiring participation of all children or even the entire population; and whether they would be willing to participate in the program themselves. We found that people were significantly more troubled by pharmacological as opposed to non-pharmacological moral enhancement interventions. The results indicate that members of the public for the greater part oppose pharmacological moral bioenhancement, yet are open to non-biomedical means to attain moral enhancement. [248 words].
- Open Access
- 12 August 2016
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 3 (3) , 447-467
Public attitudes toward legally coerced biological treatments of criminals
How does the public view the offer of a biological treatment in lieu of prison for criminal offenders? Using the contrastive vignette technique, we explored this issue, using mixed-methods analysis to measure concerns regarding changing the criminal's personality, the coercive nature of the offer, and the safety of the proposed treatment. Overall, we found that of the three variables, the safety of the pill had the strongest effect on public acceptance of a biological intervention. Indeed, it was notable that the public was relatively sanguine about coercive offers of biological agents, as well as changing the personality of criminals. While respondents did not fully endorse such coercive offers, neither were they outraged by the use of biological treatments of criminals in lieu of incarceration. These results are discussed in the context of the retributive and rehabilitative sentiments of the public, and legal jurisprudence in the arena of human rights law.
- 12 August 2016
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 3 (3) , 447-467
Open AccessPublic attitudes toward legally coerced biological treatments of criminals
How does the public view the offer of a biological treatment in lieu of prison for criminal offenders? Using the contrastive vignette technique, we explored this issue, using mixed-methods analysis to measure concerns regarding changing the criminal's personality, the coercive nature of the offer, and the safety of the proposed treatment. Overall, we found that of the three variables, the safety of the pill had the strongest effect on public acceptance of a biological intervention. Indeed, it was notable that the public was relatively sanguine about coercive offers of biological agents, as well as changing the personality of criminals. While respondents did not fully endorse such coercive offers, neither were they outraged by the use of biological treatments of criminals in lieu of incarceration. These results are discussed in the context of the retributive and rehabilitative sentiments of the public, and legal jurisprudence in the arena of human rights law.
- Open Access
- 1 September 2014
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 1 (3) , 322-327
Buttressing regulation of cognitive enhancement devices with principles of harm reduction
Maslen and colleagues offer an excellent model for regulating cognitive enhancement devices (CEDs), and we largely endorse their approach of extending medical device policy to include CEDs. Maslen et al. argue that since the risks and benefits of CEDs can be identified, consumers are best placed to evaluate the impact of these effects on their own wellbeing: ‘experts are to assess what the risks are, the consumer how much they matter’. In principle, we agree: consumers should be allowed to decide what risks are worth taking, but the situation is somewhat more complicated, for the evidence that consumers are in a strong position to evaluate the many risks associated with CED use is lacking. Indeed, a glance at online forums on CEDs suggests that undue risks are already being taken. Importantly, given the ease with which devices can be built using easily obtainable parts, overly tough regulation will not effectively curtail use, but rather push it underground. For these reasons, we suggest that any regulatory framework be buttressed by principles of harm reduction, providing real-world users with expert-backed recommendations for safe use. We argue for the development of tools that facilitate this dialogue, while recognizing the challenges in so doing.
- 1 September 2014
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 1 (3) , 322-327
Open AccessButtressing regulation of cognitive enhancement devices with principles of harm reduction
Maslen and colleagues offer an excellent model for regulating cognitive enhancement devices (CEDs), and we largely endorse their approach of extending medical device policy to include CEDs. Maslen et al. argue that since the risks and benefits of CEDs can be identified, consumers are best placed to evaluate the impact of these effects on their own wellbeing: ‘experts are to assess what the risks are, the consumer how much they matter’. In principle, we agree: consumers should be allowed to decide what risks are worth taking, but the situation is somewhat more complicated, for the evidence that consumers are in a strong position to evaluate the many risks associated with CED use is lacking. Indeed, a glance at online forums on CEDs suggests that undue risks are already being taken. Importantly, given the ease with which devices can be built using easily obtainable parts, overly tough regulation will not effectively curtail use, but rather push it underground. For these reasons, we suggest that any regulatory framework be buttressed by principles of harm reduction, providing real-world users with expert-backed recommendations for safe use. We argue for the development of tools that facilitate this dialogue, while recognizing the challenges in so doing.
- Open Access
- 8 January 2014
- Published by Springer Nature in BMC Family Practice
- Vol. 15 (1) , 3
Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany
Primary care physicians are gate keepers to the medical system having a key role in giving information and prescribing drugs to their patients. In this respect they are involved in claims of patients/clients for pharmacological Cognitive Enhancement (CE). Therefore, we studied the knowledge of primary care physicians about CE and their attitudes toward prescribing CE drugs to healthy subjects.
- 8 January 2014
- Published by Springer Nature in BMC Family Practice
- Vol. 15 (1) , 3
Open AccessAttitudes towards prescribing cognitive enhancers among primary care physicians in Germany
Primary care physicians are gate keepers to the medical system having a key role in giving information and prescribing drugs to their patients. In this respect they are involved in claims of patients/clients for pharmacological Cognitive Enhancement (CE). Therefore, we studied the knowledge of primary care physicians about CE and their attitudes toward prescribing CE drugs to healthy subjects.
- 28 August 2013
- Published by Springer Nature in Neuroethics
- Vol. 7 (2) , 173-188
Public Attitudes Toward Cognitive Enhancement
- 28 August 2013
- Published by Springer Nature in Neuroethics
- Vol. 7 (2) , 173-188
Public Attitudes Toward Cognitive Enhancement
- Open Access
- 3 June 2013
- Published by BMJ in Journal of Medical Ethics
- Vol. 41 (5) , 410-412
The challenge of crafting policy for do-it-yourself brain stimulation
Transcranial direct current stimulation (tDCS), a simple means of brain stimulation, possesses a trifecta of appealing features: it is relatively safe, relatively inexpensive and relatively effective. It is also relatively easy to obtain a device and the do-it-yourself (DIY) community has become galvanised by reports that tDCS can be used as an all-purpose cognitive enhancer. We provide practical recommendations designed to guide balanced discourse, propagate norms of safe use and stimulate dialogue between the DIY community and regulatory authorities. We call on all stakeholders—regulators, scientists and the DIY community—to share in crafting policy proposals that ensure public safety while supporting DIY innovation.
- 3 June 2013
- Published by BMJ in Journal of Medical Ethics
- Vol. 41 (5) , 410-412
Open AccessThe challenge of crafting policy for do-it-yourself brain stimulation
Transcranial direct current stimulation (tDCS), a simple means of brain stimulation, possesses a trifecta of appealing features: it is relatively safe, relatively inexpensive and relatively effective. It is also relatively easy to obtain a device and the do-it-yourself (DIY) community has become galvanised by reports that tDCS can be used as an all-purpose cognitive enhancer. We provide practical recommendations designed to guide balanced discourse, propagate norms of safe use and stimulate dialogue between the DIY community and regulatory authorities. We call on all stakeholders—regulators, scientists and the DIY community—to share in crafting policy proposals that ensure public safety while supporting DIY innovation.